HOME >> MEDICINE >> NEWS
Using cocaine during pregnancy may damage developing fetuses, causing lifelong learning disabilities

New Haven, Conn. Taking cocaine during pregnancy causes possibly permanent changes in an area of the brain that governs short term memory leading to symptoms that are very much like attention deficit hyperactivity disorder, Yale researchers have found in two recent studies.

The research team in the Neuropsychopharmacology Laboratory at Yale School of Medicine found that prenatal exposure to cocaine leads to over-stimulation of the medical prefrontal cortex of the brain in the offspring, and a dramatic impairment in learning.

"Children exposed to cocaine in the womb may have a problem with excitable neurons in part of the brain that helps control attention and memory," said Bret Morrow, associate research scientist, associate clinical professor and lead author of both studies. "Potentially, this excitable prefrontal cortex may be the basis of the learning deficits in these children."

"The use of cocaine among women of childbearing age is alarmingly high," he added. "When a pregnant woman uses cocaine she also exposes her fetus to the drug. Studies have shown that these cocaine exposed children have increased occurrence of symptoms similar to those seen with attention deficit hyperactivity disorder increased distractibility, impulsivity and select learning deficits. Based on our animal studies, we are concerned the effects could very well be lifelong in humans."

The first study published in the February issue of Behavioral Brain Research involved administering cocaine to pregnant rats and then assessing short term memory in the offspring when they were adolescents and adults.

The test animals were placed in a cage with two identical objects. They were then removed from the cage for a brief interval, and then put back in with one of the former objects and a second new object. If the animal explored the new object preferentially, that was taken as evidence that the animal remembered the first object. The test is similar to one
'"/>

Contact: Jacqueline Weaver
jacqueline.weaver@yale.edu
203-432-8555
Yale University
18-Feb-2002


Page: 1 2

Related medicine news :

1. Using the internets power and anonymity to reduce problem drinking
2. Using celebrities to market drugs and diseases: whats the problem?
3. Using over-the-counter drugs to treat upper respiratory infections may save $4.75 billion annually
4. Using smart fluids to retrain muscles
5. Using smaller hearts could increase donor pool
6. CNS cancers and other diseases: Using proteomics to identify unique protein fingerprints
7. Using vitamin E and C supplements together may reduce risk of Alzheimer disease
8. Using fMRI technology to understand hyperlexia
9. Using their heads
10. Using naltrexone to treat alcoholics with a Mediterranean drinking pattern
11. Using PET scan technology to study alcohols effects on the brain

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/23/2017)... (PRWEB) , ... April 23, 2017 , ... ... and managed services announced the achievement of Cisco Select certification and SMB specialization. ... the United States. , In earning the Select Certification, Altura fulfilled ...
(Date:4/22/2017)... , ... April 22, 2017 , ... ... that U.S. consumers can save an average of 70% when buying medication online ... to 97%) are available when purchasing from other countries. The report (chart below) ...
(Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article ... ancient teeth, which reveal a great deal about prehistoric ice-age dental practitioners and their ... have been used to remove decayed dental matter, and that teeth were then filled ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... ... professor Christopher Salas-Wright finds that youth violence is declining—and at noteworthy rates. Between ... relative proportion of young people involved in violence in the United States. The ...
(Date:4/21/2017)... ... April 21, 2017 , ... Brady (NYSE:BRC), a global ... B-595 and B-7569 vinyl label materials received certification for the BS5609 ... tested to remain intact and legible, for use on chemical drums shipped by sea. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017 Research and Markets has ... and Market Prospects: Addressing Production Complexities Through Risk Management ... ... Biosimilar Pipeline and Market Prospects: Overcoming Production Complexities Through ... assessment of the current trends in the global biosimilars ...
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
Breaking Medicine Technology:
Cached News: